Cover Image

No beneficial use of the wearable cardioverter defibrillator among patients suffering from inherited and congenital heart disease: data from a European multicenter registry

Background: Data on the use of the wearable cardioverter defibrillator in patients suffering from inherited and congenital heart disease are limited. Consequently, evidence for guideline recommendations in this patient population is lacking. Methods: In total 1,675 patients were included in a multic...

Full description

Saved in:
Bibliographic Details
Main Authors: Koepsel, Katharina (Author) , Dreher, Tobias C. (Author) , Blockhaus, Christian (Author) , Gotzmann, Michael (Author) , Klein, Norbert (Author) , Kuntz, Thomas (Author) , Shin, Dong-In (Author) , Lapp, Hendrik (Author) , Schiedat, Fabian (Author) , Abumayyaleh, Mohammad S. A. (Author) , Beiert, Thomas (Author) , Weth, Christian (Author) , Kovacs, Boldizsar (Author) , Rosenkaimer, Stephanie (Author) , Kowitz, Jacqueline (Author) , Saguner, Ardan Muammer (Author) , Erath, Julia W. (Author) , Duru, Firat (Author) , Mügge, Andreas (Author) , Akın, Ibrahim (Author) , Aweimer, Assem (Author) , Hamdani, Nazha (Author) , El-Battrawy, Ibrahim (Author)
Format: Article (Journal)
Language:English
Published: 10 July 2024
In: Frontiers in Cardiovascular Medicine
Year: 2024, Volume: 11, Pages: 1-9
ISSN:2297-055X
DOI:10.3389/fcvm.2024.1384736
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.3389/fcvm.2024.1384736
Verlag, kostenfrei, Volltext: https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2024.1384736/full
Get full text
Author Notes:Katharina Koepsel, Tobias C. Dreher, Christian Blockhaus, Michael Gotzmann, Norbert Klein, Thomas Kuntz, Dong-In Shin, Hendrik Lapp, Fabian Schiedat, Mohammad Abumayyaleh, Thomas Beiert, Christian Weth, Boldizsar Kovacs, Stephanie Rosenkaimer, Jacqueline Kowitz, Ardan Muammer Saguner, Julia W. Erath, Firat Duru, Andreas Mügge, Ibrahim Akin, Assem Aweimer, Nazha Hamdani, Ibrahim El-Battrawy
Description
Summary:Background: Data on the use of the wearable cardioverter defibrillator in patients suffering from inherited and congenital heart disease are limited. Consequently, evidence for guideline recommendations in this patient population is lacking. Methods: In total 1,675 patients were included in a multicenter registry of eight European centers. In the present cohort, we included 18 patients suffering from congenital and inherited heart disease. Results: Nine patients (50%) were male with a mean age of 41.3 ± 16.4 years. Four patients suffered from hypertrophic cardiomyopathy (HCM), four patients suffered from non-compaction cardiomyopathy (NCCM), two patients were diagnosed with arrhythmogenic right ventricular cardiomyopathy (ARVC) and one patient suffered from muscular dystrophy of the limb-girdle type with cardiac involvement, secondary cardiomyopathy. Three patients presented with Brugada syndrome (BrS). One patient suffered from long-QT syndrome type 1 (LQTS1). Furthermore, two patients had congenital heart defects and one patient suffered from cardiac sarcoidosis (CS). There were no appropriate/inappropriate shocks with the WCD in this cohort. One patient had recurrent self-limiting sustained ventricular tachycardia during the wear time, but actively inhibited a shock and was hospitalized. The compliance rate in this cohort was 77.8% with a mean wear time of 45.3 ± 26.9 days with a mean follow-up time of 570 ± 734 days. 55.6% (10/18) of the patients received an ICD after WCD wear time. Conclusions: This retrospective study of patients with inherited and congenital heart disease shows that WCD use is not beneficial in the majority of patients with inherited and congenital heart disease.
Item Description:Gesehen am 11.02.2025
Physical Description:Online Resource
ISSN:2297-055X
DOI:10.3389/fcvm.2024.1384736

Similar Items